NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance. [electronic resource]
Producer: 20161007Description: 42569-74 p. digitalISSN:- 1949-2553
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- CD56 Antigen -- biosynthesis
- Female
- Flow Cytometry
- GPI-Linked Proteins -- biosynthesis
- Histamine -- administration & dosage
- Humans
- Immunotherapy -- methods
- Interleukin-2 -- administration & dosage
- Kaplan-Meier Estimate
- Killer Cells, Natural -- immunology
- Leukemia, Myeloid, Acute -- immunology
- Lymphocyte Subsets -- immunology
- Maintenance Chemotherapy -- methods
- Male
- Middle Aged
- Natural Cytotoxicity Triggering Receptor 1 -- biosynthesis
- Natural Cytotoxicity Triggering Receptor 3 -- biosynthesis
- Neoplasm Recurrence, Local -- immunology
- Receptors, IgG -- biosynthesis
- Recombinant Proteins -- administration & dosage
- Remission Induction
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.